Find your next paid study

Fred Hutchinson Cancer CenterNCT07141407

The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patien…

Adrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more

Children's Oncology GroupNCT02402244

~$10 – $1,125

Metastatic Biliary Tract CarcinomaMetastatic Colon CarcinomaMetastatic Esophageal Carcinoma+5 more

A Phase Ib/II Basket Study of BMS-986504 in Combination With Pemetrexed for Metastatic Solid Tumors With MTAP Deletion

This phase Ib/II trial tests the safety and side effects of BMS-986504 in combination with pemetrexed and how well the combination works in treating patients w…

Northwestern UniversityNCT07594626

Observational

CREATE: Clinical Research Examining the Arts as Targeted Elements in Childhood Cancer Care

This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos c…

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

OHSU Knight Cancer InstituteNCT06342453

~$10 – $7,500

Colorectal CarcinomaEndometrial CarcinomaMelanoma+19 more

A Phase 1/2 Study of Tegavivint (NSC#826393) in Children, Adolescents, and Young Adults With Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

This phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come b…

~$10 – $7,500

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm

A Molecularly Driven Phase 1b Dose Escalation and Dose Expansion Study of the DNA-PK Inhibitor Peposertib (M3814) in Combination With the ATR Inhibitor Tuvusertib (M1774)

This phase I trial tests the safety, side effects and best dose of peposertib (M3814) in combination with tuvusertib (M1774) in treating patients with solid tu…

National Cancer Institute (NCI)NCT05687136

~$10 – $5,625

Observational

ONE SHOT: Single-Fraction Adaptive MR-Guided Radiation Therapy for Metastatic Solid Tumors

This clinical trial studies the side effects of magnetic resonance (MR)-guided stereotactic body radiation therapy (SBRT) and to see how well it works in treat…

Metastatic Malignant Solid Neoplasm

Jonsson Comprehensive Cancer CenterNCT07671768

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

This study performs standardized testing of tumor tissue samples to learn which genes are mutated (have changed) in order to provide personalized cancer therap…

GliomaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+2 more

M.D. Anderson Cancer CenterNCT01772771

~$10 – $750

Validation of DNA Methylation Markers for the Universal and Site-Specific Guided Cancer Detection (the VANGUARD Study)

This study explores the potential value of a new blood test approach for early detection of cancer.

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

~$10 – $750

Mayo ClinicNCT06304168

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more

A Phase I/II Study of Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab in Advanced Solid Tumors (PNeoVCA)

This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patient…

Metastatic Malignant Solid Neoplasm

A Pilot Study of Spatiotemporal SBRT for Poly-Metastatic Cancer

This clinical trial evaluates the safety and effectiveness of spatiotemporal stereotactic body radiation therapy (ST-SBRT) in treating patients with solid tumo…

City of Hope Medical CenterNCT05733949

Phase 3

Pre-Operative vs. Post-Operative Stereotactic Radiosurgery for Operative Metastatic Brain Tumors

This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has sprea…

Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain